bpc 157 body protection compound 157 BPC-157 for athletes and injury treatment: Science, safety, and legal concerns The "Body Protection Compound": A

***12 mg requires 3 vials (15 mg total in 3.0 mL)

Importantly, BPC-157 is currently classified as a research peptide

Repeated administration of any synthetic peptide can provoke antibody formation, and the chronic dosing schedules sold by clinics have not been characterised in humans for this molecule [9]

However in our opinion, the low probability of MS coincidence with another rare disease, together with the animal studies where MS is never a consideration, makes it more likely that these human examples align with an inside-out model (Figure 2), where a primary biochemical derangement of myelin, coupled with an immune predisposition, culminated in a MS-like phenotype